# CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants

> **NCT00788567** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 136 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** mycophenolate mofetil

## Key facts

- **NCT ID:** NCT00788567
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 136 (ACTUAL)
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788567, "CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney Transplants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00788567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*